menu search

How amazon's cloud unit is helping researchers analyze genetics

AWS has launched general availability for Amazon Omics, which helps researchers store and analyze omic data like sequences of DNA, RNA and proteins....

December 28, 2022, 9:00 am

Adaptive biotechnologies to present at the 41st annual j.p. morgan healthcare conference

SEATTLE, Dec. 27, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage b...

December 27, 2022, 9:05 pm

Adaptive biotechnologies to present at the 41st annual j.p. morgan healthcare conference

SEATTLE, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage bi...

December 27, 2022, 4:05 pm

4 top biotech stocks worth adding to your portfolio in 2023

New drug approvals and focus on coronavirus treatments should maintain momentum for the Zacks Biomedical and G...

December 27, 2022, 12:47 pm

Astria therapeutics: tailwinds building with novel treatment paradigm

ATXS has broken out from a 37-week price reversal. Hereditary angioedema is a rare genetic disorder cha...

December 24, 2022, 12:38 am

Proqr (prqr) rises on expanding rna-editing deal with eli lilly

ProQR (PRQR) expands its existing licensing and collaboration agreement with Eli Lilly for the discovery, development and commercialization of new g...

December 23, 2022, 1:32 pm

Wellbeing digital sciences says kgk subsidiary gets ok to proceed with phase ii a clinical trial assessing psilocybin therapy for fragile x syndrome

Wellbeing Digital Sciences Inc (NEO:MEDI.AQN, OTCQB:KONEF) announced that its wholly-owned subsidiary KGK Sciences Inc has received a 'No Objection le...

December 23, 2022, 6:44 am

Proqr's stock jumps on expanded rna deal with lilly

Shares of ProQR Therapeutics NV PRQR, +1.85% soared 56.3% in premarket trading on Thursday after the company said it expanded an RNA editing deal with...

December 22, 2022, 9:12 am

eneti: set for solid growth over the next few years

Long-term growth trajectory looks good for NETI as supply is expected to tighten up in the latter part of the decade from shortage of installation ves...

December 16, 2022, 3:54 am

Infertility market size worth usd 3,650 million by 2030 at 12.8% cagr – report by market research future (mrfr)

Infertility Market Trends and Insights By Sex (Males, Females And Unexplained), By Diagnosis (Men Diagnostic Tests (Semen Analysis, G...

December 15, 2022, 12:30 am

New england journal of medicine publishes phase 3 data on b-vec in patients with dystrophic epidermolysis bullosa

PITTSBURGH, Dec. 14, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a biotechnology company focused on developing...

December 14, 2022, 10:00 pm

Qiagen's (qgen) therascreen kras kit receives fda approval

QIAGEN's (QGEN) therascreen-based companion diagnostic detects KRAS G12C, a genetic mutation that is on...

December 14, 2022, 12:47 pm

Adaptive biotechnologies highlights new data showcasing the clinical utility of clonoseq® mrd testing in patients with blood cancers at the 64th ash annual meeting

Multiple presentations reinforce clonoSEQ’s ability to provide valuable insights for treatment surveillance and clinical decision-making More than 3...

December 10, 2022, 3:00 pm

Myriad genetics patient outcomes study shows riskscore leads to more accurate breast cancer risk prediction than standard-of-care risk model

Myriad’s MyRisk™ Hereditary Cancer test with RiskScore® provides a personalized breast cancer risk assessment for women of all ancestries SALT LA...

December 9, 2022, 12:15 am

Entrada therapeutics shares jump on collaboration with vertex

Shares of Entrada Therapeutics Inc. TRDA, +3.20% rallied 15% in premarket trading on Thursday after the company announced a deal with Vertex Pharmaceu...

December 8, 2022, 8:24 am

Biogen's (biib) als drug tofersen filing accepted in europe

Biogen's (BIIB) tofersen, if approved, will be the first genetically-targeted treatment for SOD1-ALS in...

December 6, 2022, 11:17 am

Cogent biosciences to host investor webcast to discuss updated clinical data at ash from the ongoing phase 2 apex trial of bezuclastinib in patients with advanced systemic mastocytosis

WALTHAM, Mass. and BOULDER, Colo., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc.  (Nasdaq: COGT), a biotechnology company focused on dev...

December 5, 2022, 8:00 am

Beam therapeutics named to boston globe’s top places to work list for 2022

Beam Ranked No. 4 in Large Companies Category, Marking Fourth Consecutive Year as Top Workplace in Massachusetts CAMBRIDGE, Mass., Dec. 02, 2022 (GLOB...

December 2, 2022, 7:00 pm

Eloxx pharmaceuticals announces reverse stock split effective

ELOX common stock expected to begin trading on a split-adjusted basis on December 2, 2022 WATERTOWN, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) — Eloxx P...

December 1, 2022, 1:45 pm

eneti (neti) is a great choice for 'trend' investors, here's why

eneti (NETI) could be a solid choice for shorter-term investors looking to capitalize on the recent pri...

December 1, 2022, 10:32 am


Search within

Pages Search Results: